Further study is required to determine the role of RASA1 in melanomas with oncogenic NRAS mutations, especially in metastasis, and the effect of RASA1 on R-Ras activation in melanomas that are wild-type for BRAF and NRAS. The gene discussed is RRAS; the disease is melanoma.